When pharmaceutical companies and health plans needed a better way to exchange clinical and economic evidence, no standard existed.
We built one.
We created the previous industry standard for evidence exchange — used by the majority of US health plans to request and access drug evidence from manufacturers.
Now we’re building what comes next.
Nine leaders from payer, pharma, health economics, and technology.
One platform that changes how drugs are valued.